SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation
- DOI
- 10.1172/jci199709
- Published
- 2026-07-15
- Container
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci199709,
title = {SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation},
author = {Haojun Yang and Vincenzo Andrea Zingaro and Kevin Boardman and Ashish Noronha and Ekin Guney and Lingru Xue and Saishma Hoigebazar and Isabelle Liu and Sohit Miglani and Siyu Chen and Hieu Vu and Kwun Wah Wen and Hao G. Nguyen and Hani Goodarzi and Ralph J. DeBerardinis and Davide Ruggero},
year = {2026},
journal = {Journal of Clinical Investigation},
doi = {10.1172/jci199709},
url = {https://doi.org/10.1172/jci199709}
}RIS
TY - JOUR TI - SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation AU - Haojun Yang AU - Vincenzo Andrea Zingaro AU - Kevin Boardman AU - Ashish Noronha AU - Ekin Guney AU - Lingru Xue AU - Saishma Hoigebazar AU - Isabelle Liu AU - Sohit Miglani AU - Siyu Chen AU - Hieu Vu AU - Kwun Wah Wen AU - Hao G. Nguyen AU - Hani Goodarzi AU - Ralph J. DeBerardinis AU - Davide Ruggero PY - 2026 JO - Journal of Clinical Investigation DO - 10.1172/jci199709 UR - https://doi.org/10.1172/jci199709 ER -
APA
Yang, H., Zingaro, V. A., Boardman, K., Noronha, A., Guney, E., Xue, L., Hoigebazar, S., Liu, I., Miglani, S., Chen, S., Vu, H., Wen, K. W., Nguyen, H. G., Goodarzi, H., DeBerardinis, R. J., & Ruggero, D. (2026). SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation. Journal of Clinical Investigation. https://doi.org/10.1172/jci199709
Source records
- crossref · retrieved 2026-09-25T20:36:33.948Z